Clinical Trials in Boston

Showing 6761-6780 of 13,548 trials

Novel Cardiac Signal Processing System

NCT04112433

This study is designed to collect parallel intracardiac signal data during pre-defined periods of clinical interest from the PURE EP system and the existing signal recording and mapping systems. The collected signals will then undergo BLINDED, CONTROLLED evaluation by unbiased electrophysiologist reviewer(s) to determine whether the PURE EP signals provides additional or clearer diagnostic information.

Cardiac Arrhythmia

BioSig Technologies, Inc.104 participantsStarted Nov 2019

Jacksonville, Florida, United States • Boston, Massachusetts, United States • Austin, Texas, United States

TERMINATEDPhase 2< 1 mile

X-82 to Treat Age-related Macular Degeneration

NCT02348359

The purpose of this study is to evaluate the safety and efficacy of X-82 in the treatment of vision loss due to wet AMD.

Tyrogenex157 participantsStarted Mar 2015

Tucson, Arizona, United States • Beverly Hills, California, United States • Huntington Beach, California, United States +32 more locations

Novel Cardiac Signal Processing System

X-82 to Treat Age-related Macular Degeneration

Find Trials by Condition in Boston

PREventing Adverse Events Post-Discharge Through Proactive Identification, Multidisciplinary Communication, and Technology

Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD)

Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.

The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

Safety Study of MGA271 in Refractory Cancer

Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Feasibility of Telemedicine Medical Abortion

Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease

Effect of Pre-imaging on Cardiopulmonary Resuscitation (CPR) Pause

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition